Anticipatory Counseling on LNG-IUS Continuation, Utilization and Satisfaction
ACCCUSS
1 other identifier
interventional
178
1 country
3
Brief Summary
This study is a counseling intervention for new LNG-IUS users. The study explores the use of video technology to deliver anticipatory counseling on LNG-IUS side-effects, adjustment periods and bleeding changes to women newly using the LNG-IUS for contraceptive purposes. The primary aim is to understand if anticipatory counseling delivered via video can increase LNG-IUS satisfaction and continuation of the device in the first 6 months of use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2016
CompletedFirst Submitted
Initial submission to the registry
April 15, 2016
CompletedFirst Posted
Study publicly available on registry
April 26, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedApril 18, 2019
April 1, 2019
3.6 years
April 15, 2016
April 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in LNG-IUS knowledge, satisfaction and continuation from baseline
Using standardize questionnaires we will assess any significant differences in LNG-IUS knowledge, satisfaction or continuation after 6 months between control arm and intervention arm subjects.
6 months
Secondary Outcomes (4)
Percent of subjects in Phase II who complete all 3 surveys on-time over 6 months compared by recruitment method and site
6 months
Number of subjects reporting LNG-IUS discontinuation during the study time frame (6 months) by reason for LNG-IUS removal
6 months
LNG-IUS user self-reported satisfaction with video counseling
6 months
LNG-IUS user self-reported LNG-IUS healthcare utilization during study period
baseline, 3 months, 6 months
Study Arms (2)
Control Video
SHAM COMPARATORParticipants in this study arm will be assigned to watch a short educational video about new pap screening guidelines for women. Intervention: Cancer Screening Guidelines.
Intervention Video
ACTIVE COMPARATORParticipants in this group will be assigned to watch a short educational video providing anticipatory counseling on their LNG-IUS' side effects and expected changes in bleeding. Intervention: Anticipatory Counseling
Interventions
Anticipatory Counseling provides information on expected side-effects that may change or go away over time, or stay for the duration of the treatment. Anticipatory counseling can also help patients understand when their side-effects are normal and when to seek medical attention.
Anticipatory Counseling on United States Preventative Services Task Force (USPSTF) updated pap screening guidelines
Eligibility Criteria
You may qualify if:
- Women aged 18 and over who are deemed appropriate candidates be their healthcare providers and choose to use LNG-IUS, either Mirena or Skyla.
- Within five days of FIRST using either Mirena or Skyla
- Willing to answer online questions before and after watching the assigned video (intervention or control)
- Willing to complete short online questionnaire at three and six months
- Has working email and/or phone number
- Able to understand verbal and written English
- Appropriate LNG-IUS candidates whoa re being treated for other pre-existing medical disorders while using the LNG IUS may continue to take their medications as directed by their healthcare provider.
You may not qualify if:
- Women aged less than 18 years old
- Initiated LNG-IUS method more than five days from enrollment date.
- Within six weeks postpartum
- Breastfeeding
- Using LNG-IUS for treatment other than contraception
- Do not have access to the Web
- Have neither working email or phone number
- Does not understand written or verbal English
- Inappropriate candidates for LNG IUS as deemed by healthcare provider
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- Bayercollaborator
- Cook County Healthcollaborator
- University of California, Los Angelescollaborator
Study Sites (3)
University of California Los Angeles Medical Center
Los Angeles, California, 90095, United States
Stroger Hospital of Cook County
Chicago, Illinois, 60612, United States
University of Washington Medical Centers
Seattle, Washington, 98112, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily Godfrey, MD, MPH
University of Washington
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Family Medicine
Study Record Dates
First Submitted
April 15, 2016
First Posted
April 26, 2016
Study Start
March 1, 2016
Primary Completion
October 1, 2019
Study Completion
December 1, 2019
Last Updated
April 18, 2019
Record last verified: 2019-04